Newsmeme!
Discover News you didn't know existed
Blood Platelets
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
After long delays, FDA OKs Lilly's blood thinner, but with major caveat
Published July 10, 2009, 10:57 pm, The Indianapolis Star
Drug maker must put black label on Effient's packaging warning of potentially fatal bleeding in some patients.
Lilly, Daiichi Sankyo Gain U.S. Backing for Plavix Competitor
Published July 10, 2009, 9:54 pm, Bloomberg
Lilly’s medicine, prasugrel, was cleared yesterday by the Food and Drug Administration and will be sold under the name Effient, the agency said in an e-mail. The drug will carry the FDA’s strictest warning, known as a black box, to doctors about an increased risk of potentially fatal bleeding.
FDA clears Eli Lilly's blood thinner Effient
Published July 10, 2009, 9:09 pm, The Uniontown Herald Standard
WASHINGTON (AP) - The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.
F.D.A. Approves Eli Lilly Blood Thinner, With a Warning
Published July 10, 2009, 6:47 pm, New York Times
Effient will become the first real competition to Plavix, a blood thinner made by Sanofi-Aventis and Bristol-Myers Squibb.
FDA Approves Blood Thinner Effient
Published July 10, 2009, 4:40 pm, CBS 3 Philadelphia
The Food and Drug Administration has approved a highly anticipated blood thinner from Eli Lilly after more than 18 months of review. The approval makes Lilly's Effient the first real competition to the blood thinner Plavix, the world's second-best selling medication made by Sanofi-Aventis and Bristol-Myers Squibb.
Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
Published July 10, 2009, 3:23 pm, redOrbit
PARSIPPANY, N.J. and INDIANAPOLIS, July 10 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc. and Eli Lilly and Company (NYSE: LLY) today announced that the U.S.
Blood thinner Effient gets FDA approval -- with warning
Published July 10, 2009, 3:12 pm, USA Today
The U.S. Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.
Lilly, Daiichi Sankyo Win Approval of Prasugrel (Update2)
Published July 10, 2009, 2:54 pm, Bloomberg
Lilly’s medicine, prasugrel, was cleared by the Food and Drug Administration and will be sold under the name Effient, the agency said today in an e-mail. The drug will carry the FDA’s strictest warning, known as a black box, to doctors about an increased risk of potentially fatal bleeding.
Effient Sanctioned for Angioplasty Patients
Published July 10, 2009, 2:44 pm, Forbes
To reduce the risk of blood clots
FDA clears Eli Lilly's blood thinner Effient
Published July 10, 2009, 2:43 pm, Deseret News
The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |